The Raf #kinase #inhibitors #Dabrafenib and #Regorafenib impair #Zika virus #replication via distinct mechanisms, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00618-24?af=R

This study provides further insight into ZIKV-host interactions and has implications for the development of novel #antivirals against ZIKV and possibly other #flaviviruses.

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc

๐Ÿ’Š๐Ÿ’‰ #regorafenib
SmPC for Stivarga 40 mg film-coated tablets. has been updated with changes to sections 4.4 Special warnings and precautions for use; 10. Date of revision of the text on 15 May 2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/1263/smpc
Change log: https://www.medicines.org.uk/emc/product/1263/smpc/history
Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Stivarga 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Bayer plc